news
British Columbia first province to switch patients to biosimilars
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
List view / Grid view
Supply Chain
article
Is the pharma sector ready for a ‘no-deal’ Brexit?
With the UK bracing itself for a 'no-deal' Brexit or some other outcome that has not yet been determined, pharma experts discussed the potential effect of Brexit on the supply chain and how to best prepare for it against the upcoming deadline.
news
FDA identifies hundreds of devices affected by sterilisation facility closures
FDA has launched a notification system where device manufacturers and users may notify the agency of any shortages or related supply issues stemming from sterilisation facility shutdowns...
whitepaper
Whitepaper: Emerging trends in regulatory expectations
Regulatory expectations nowadays focus on harmonisation of global regulations. This whitepaper by PQE looks at current and emerging trends in regulatory expectations.
article
The potential of blockchain in a regulatory environment
Blockchain technologies have the potential to improve transparency, efficiency and reliability of transactions in a heavily regulated pharmaceutical industry. However, there are challenges and limitations. Nikki Withers speaks to Bob Celeste, founder of the Centre for Supply Chain Studies, who has been exploring the potential use of blockchain technology to…
news
Perigord announces the release of GLAMS CMO
Simplify your artwork process, get closer to your customers and strengthen compliance...
news
FDA launches pilot programme to track and trace US supply chain
The pilot project will test innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the US...
news
DHL launches express cold chain service between Brazil and the US
Service expansion in Brazil will meet transportation demands of the pharmaceutical and clinical research industry...
article
Expert View: What ADC evolution means for manufacturing
The evolution of antibody-drug conjugates (ADCs) is a spectacular example of how global research can sculpt a new technology. Years of molecular and cell biology, conjugation chemistry and immunology progress has enabled a cytotoxic agent paired with a tumour-specifi c antibody to become mainstream cancer therapy.1 Today, advances continue, explains…
product
Thermo Scientific microPHAZIR RX handheld NIR analyser
microPHAZIR RX handheld analyzer is used by pharmaceutical manufacturers for GMP compliant incoming raw material identification, quality control and assurance, and at-line PAT.
whitepaper
Whitepaper: The impacts of Brexit on the bio/pharmaceutical industry
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
product
True supply chain security is an eFingerprint away
Systech is the global technology leader in supply chain security and product authentication. For more than 30 years, we have put technology on the line...
news
Pharmaceutical glass packaging market to grow at 6% CAGR
North America dominates the global market for pharmaceutical glass packaging, due to the region’s technical innovation and strong demand for pharmaceutical products...
news
Pharma firms step up plans to beat Brexit supply chain disruption
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39...
webinar
Understanding the complexities of global serialisation & traceability regulations
18 September 2018 | By Clarivate Analytics
In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 percent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market do…
